Related Experiment Video
Updated: Jun 12, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity
A Barbáchano1, P Ordóñez-Morán, J M García
1Departamento de Biología del Cáncer, Instituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain.
Abstract:
SPROUTY-2 (SPRY2) regulates receptor tyrosine kinase signalling and therefore cell growth and differentiation. In this study, we show that SPRY2 expression in colon cancer cells is inhibited by the active vitamin D metabolite 1alpha,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) through E-cadherin-dependent and -independent mechanisms. In turn, SPRY2 represses both basal and 1,25(OH)(2)D(3)-induced E-cadherin expression. In line with this, SPRY2 induces ZEB1 RNA and protein, but not that of other epithelial-to-mesenchymal transition inducers that repress the CDH1/E-cadherin promoter. Consistently, SPRY2 and E-cadherin protein levels inversely correlate in colon cancer cell lines and xenografted tumours. Moreover, SPRY2 knockdown by small hairpin RNA increases CDH1/E-cadherin expression and, reciprocally, CDH1/E-cadherin knockdown increases that of SPRY2. In colon cancer patients, SPRY2 is upregulated in undifferentiated high-grade tumours and at the invasive front of low-grade carcinomas. Quantification of protein expression in 34 tumours confirmed an inverse correlation between SPRY2 and E-cadherin. Our data demonstrate a tumourigenic action of SPRY2 that is based on the repression of E-cadherin, probably by the induction of ZEB1, and a reciprocal regulation of SPRY2 and E-cadherin that dictates cell phenotype. We propose SPRY2 as a candidate novel marker for high-grade tumours and a target of therapeutic intervention in colon cancer.
Insights
SPROUTY-2 (SPRY2) is inhibited by vitamin D in colon cancer cells. SPRY2 represses E-cadherin, promoting tumor growth and suggesting SPRY2 as a therapeutic target and marker for high-grade colon cancers.
Area of Science:
- Molecular biology
- Cancer research
- Cell signaling
Background:
- SPROUTY-2 (SPRY2) is a negative regulator of receptor tyrosine kinase signaling, impacting cell growth and differentiation.
- Vitamin D metabolites, such as 1alpha,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), are known to influence cellular processes.
- E-cadherin is a crucial cell adhesion molecule often downregulated in cancer.
Purpose of the Study:
- To investigate the regulatory relationship between SPRY2 and E-cadherin in colon cancer.
- To explore the role of 1,25(OH)(2)D(3) in modulating SPRY2 expression and its downstream effects.
- To determine the clinical relevance of SPRY2 and E-cadherin expression in colon cancer patients.
Main Methods:
- Investigated SPRY2 expression in colon cancer cells treated with 1,25(OH)(2)D(3).
- Assessed the impact of SPRY2 on E-cadherin and epithelial-to-mesenchymal transition (EMT) markers like ZEB1.
- Analyzed SPRY2 and E-cadherin protein levels in colon cancer cell lines, xenografts, and patient tumors.
Main Results:
- 1,25(OH)(2)D(3) inhibits SPRY2 expression in colon cancer cells via E-cadherin-dependent and -independent pathways.
- SPRY2 represses both basal and 1,25(OH)(2)D(3)-induced E-cadherin expression, partly through ZEB1 induction.
- SPRY2 and E-cadherin protein levels show an inverse correlation in colon cancer cell lines, xenografts, and patient samples.
- SPRY2 is upregulated in undifferentiated, high-grade colon tumors and at the invasive front of low-grade carcinomas.
Conclusions:
- SPRY2 promotes colon tumorigenesis by repressing E-cadherin, likely via ZEB1 induction.
- A reciprocal regulatory loop exists between SPRY2 and E-cadherin, influencing colon cancer cell phenotype.
- SPRY2 is a potential biomarker for high-grade colon tumors and a target for therapeutic intervention.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Renewal of Intestinal Stem Cells
Cancer Cell Migration through Invadopodia
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...

